Mit‐O‐My I Can’t Breath! Mitomycin C–Induced Pneumonitis Leading to Acute Respiratory Distress Syndrome, a Rare Case

Mitomycin C (MMC) pneumonitis leading to acute respiratory distress syndrome (ARDS) is a rare and life-threatening adverse reaction to MMC. Diagnosing MMC pneumonitis can be challenging as more frequent etiologies such as bacterial infections are often targeted first due to patients being immunocompromised from chemotherapy. We report a case of a middle-aged male who was administered MMC without concomitant vinca alkaloid, who developed ARDS secondary to MMC pneumonitis requiring intubation and intensive care. The patient recovered with steroid treatment after being on antibiotics for many days, and no infectious etiology was ever identified. This case emphasizes the importance of recognizing MMC as a potential cause for pneumonitis which can lead to ARDS and death.

Authors

Institutions

Publication Details

Journal
Case Reports in Oncological Medicine
Published
2025-01-01
DOI
https://doi.org/10.1155/crom/5587748
Citations
1
Primary Topic
Cancer therapeutics and mechanisms
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mit‐O‐My I Can’t Breath! Mitomycin C–Induced Pneumonitis Leading to Acute Respiratory Distress Syndrome, a Rare Case

Prarthna V Bhardwaj, Tyler Steve
1 citations
Case Reports in Oncological Medicine
Cancer therapeutics and mechanisms
0.81
article

Mit‐O‐My I Can’t Breath! Mitomycin C–Induced Pneumonitis Leading to Acute Respiratory Distress Syndrome, a Rare Case

Prarthna V Bhardwaj, Tyler Steve
article en
1 citations

Abstract

Mitomycin C (MMC) pneumonitis leading to acute respiratory distress syndrome (ARDS) is a rare and life-threatening adverse reaction to MMC. Diagnosing MMC pneumonitis can be challenging as more frequent etiologies such as bacterial infections are often targeted first due to patients being immunocompromised from chemotherapy. We report a case of a middle-aged male who was administered MMC without concomitant vinca alkaloid, who developed ARDS secondary to MMC pneumonitis requiring intubation and intensive care. The patient recovered with steroid treatment after being on antibiotics for many days, and no infectious etiology was ever identified. This case emphasizes the importance of recognizing MMC as a potential cause for pneumonitis which can lead to ARDS and death.

Case Reports in Oncological MedicineVol. 2025(1)
Baystate Medical Center (US), Baystate Health (US)
Good health and well-being
Openalex Percentile: Top 27%
Cancer therapeutics and mechanisms
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.